Lineage Cell Therapeutics, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2022 | 96.6% | -122.1% | -135.3% |
| Jun 2022 | 95.3% | -93.0% | -148.5% |
| Sep 2022 | 92.2% | -175.2% | -202.4% |
| Dec 2022 | 94.7% | -346.7% | -331.8% |
| Mar 2023 | 95.0% | -278.4% | -183.2% |
| Jun 2023 | 96.1% | -155.8% | -162.1% |
| Sep 2023 | 86.4% | -538.1% | -570.6% |
| Dec 2023 | 87.7% | -304.7% | -228.7% |
| Mar 2024 | 93.2% | -461.3% | -453.0% |
| Jun 2024 | 96.9% | -416.7% | -409.1% |
| Sep 2024 | 99.0% | -101.6% | -80.3% |
| Dec 2024 | 94.6% | -178.2% | -114.1% |
| Mar 2025 | 97.6% | -433.1% | -275.6% |
| Jun 2025 | — | -715.4% | -1,101.8% |
| Sep 2025 | — | -102.9% | -809.0% |
| Dec 2025 | — | -99.1% | 12.9% |
| Mar 2026 | — | -440.2% | -279.0% |
| Jun 2026 | — | -834.7% | 138.6% |